Everest Organics (BOM:524790) FCF Margin % : 0.00% (As of Sep. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Everest Organics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Everest Organics's Free Cash Flow for the three months ended in Sep. 2024 was ₹0 Mil. Everest Organics's Revenue for the three months ended in Sep. 2024 was ₹440 Mil. Therefore, Everest Organics's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

As of today, Everest Organics's current FCF Yield % is 1.96%.

The historical rank and industry rank for Everest Organics's FCF Margin % or its related term are showing as below:

BOM:524790' s FCF Margin % Range Over the Past 10 Years
Min: -1.71 Med: 1.6 Max: 3.68
Current: 1.83

During the past 9 years, the highest FCF Margin % of Everest Organics was 3.68%. The lowest was -1.71%. And the median was 1.60%.

BOM:524790's FCF Margin % is ranked better than
52.97% of 993 companies
in the Drug Manufacturers industry
Industry Median: 0.89 vs BOM:524790: 1.83

Everest Organics FCF Margin % Historical Data

The historical data trend for Everest Organics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Everest Organics FCF Margin % Chart

Everest Organics Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

1.51

3.68

-1.71

2.67

1.69

Everest Organics Quarterly Data
	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of Everest Organics's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Everest Organics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Everest Organics's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Everest Organics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Everest Organics's FCF Margin % falls into.

Everest Organics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Everest Organics's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	33.268	/	1972.412
	=	1.69 %

Everest Organics's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	0	/	440.472
	=	0.00 %

Everest Organics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Everest Organics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Everest Organics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Everest Organics Ltd (BOM:524790) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Opposite Madhapur Police Station Road, 1st Floor, Amar Co-Operative Society, Lakeview Plaza, Plot No. 127 and 128, Near Durgam Cheruvu, Madhapur, Hyderabad, TG, IND, 500 033

Website

https://www.everestorganicsltd.com

Everest Organics Ltd is a pharmaceutical company. It is focused on manufacturing active pharmaceutical ingredients and intermediaries. The products offered by the company include Omeprazole, Ciprofloxacin, Dichloroflurobenzene, Naproxen, Benzimadizole, and others. The company operates in one primary business segment namely Active Pharmaceutical Ingredients (API) and their intermediaries. Geographically, it derives a majority of its revenue from India.

Everest Organics Headlines

No Headlines